Byron Francisco Mosquera

Mr. Byron Francisco Mosquera

Hospital Oncológico Solón Espinosa Ayala, SOLCA Núcleo de Quito, Quito, Pichincha, Ecuador
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
Byron Francisco MosqueraByron Francisco Mosquera
Byron Francisco Mosquera
NLNicolas Lopez
Nicolas Lopez
EMEduardo A. Moncayo-Palacio
Eduardo A. Moncayo-Palacio
Given the highly contagious nature of SARS-CoV-2, it has resulted in an unprecedented number of COVID-19 infected and dead people worldwide. Since there is currently no vaccine available in the market, the identification of potential drugs is urgently needed to control the pandemic. In this study, 92 phytochemicals from medicinal plants growing in the Andean region were screened against SARS-CoV-2 3 C-like protease (3CLpro) and RNA-dependent RNA polymerase (RdRp) in their active sites through molecular docking. The cutoff values were set from the lowest docking scores of the FDA-approved drugs that are being used to treat COVID-19 patients (remdesivir, lopinavir, and ritonavir). Compounds with docking scores that were lower than cutoff values were validated by molecular dynamics simulation with GROMACS, using root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration (Rg), and intermolecular hydrogen bonds (H-bonds). Furthermore, binding free energies were estimated using the MM-PBSA method, and ADMET profiles of potential inhibitors were assessed. Computational analyses revealed that the interaction with hesperidin (theoretical binding energies, ΔGbind = −15.18 kcal/mol to 3CLpro and ΔGbind = −9.46 kcal/mol to RdRp) remained stable in both enzymes, unveiling its remarkable potential as a possible multitarget antiviral agent to treat COVID-19. Importantly, lupinifolin with an estimated binding affinity to 3CLpro higher than hesperidin (ΔGbind = −20.93 kcal/mol) is also a potential inhibitor of the 3CLpro. These two compounds displayed suitable pharmacological and structural properties to be drug candidates, demonstrating to be worthy of further research. Communicated by Ramaswamy H. Sarma

22 June 2022 in Plants
Verified
Journal Article
Open access
PDF file
Byron Francisco MosqueraByron Francisco Mosquera
Byron Francisco Mosquera
Francisco FloresFrancisco Flores
Francisco Flores
EMEduardo Moncayo
Eduardo Moncayo
BGBrighitte A. Garzón-Proaño
Brighitte A. Garzón-Proaño
MMMiguel Méndez
Miguel Méndez
CNCarlos Noceda
Carlos Noceda
Babaco is a fast-growing herbaceous shrub with great commercial potential because of the organoleptic properties of its fruit. Babaco mosaic virus (BabMV) is a potexvirus in the family Alphaflexiviridae affecting babaco in all the provinces that produce this crop in Ecuador. BabMV was recently described but it has been affecting babaco for decades and, since many potexviruses are serologically indistinguishable, it may have been previously misidentified as papaya mosaic virus. Based on the coat protein (CP) gene, we aimed to study the distribution and epidemiological patterns of BabMV in babaco and chamburo over the years and to model its three-dimensional structure. Sequences of the CP were obtained from thirty-six isolates from plants collected in the main babaco-producing provinces of Ecuador between 2016 and 2021. The evolution rate of BabMV was estimated at 1.21 × 10−3 nucleotide substitutions site−1 year−1 and a time of origin of the most recent common ancestor around 1958.80. From molecular dynamics simulations, compared to other proteins of BabMV—RDRP, TGB1, and Alkb domain—the CP exhibited a higher flexibility with the C and N terminals as the most flexible regions. The reconstructed viral distribution provides dispersion patterns which have implications for control approaches of BabMV.

6 November 2019 in Virus Genes
Verified
Journal Article
Closed access
PDF file
Byron Francisco MosqueraByron Francisco Mosquera
Byron Francisco Mosquera
PGPatricia Garrido
Patricia Garrido
Francisco FloresFrancisco Flores
Francisco Flores

20 October 2025 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
Byron Francisco MosqueraByron Francisco Mosquera
Byron Francisco Mosquera
DPDavid Larrea P.
David Larrea P.
OROscar Ramos
Oscar Ramos
BLBeatriz Luna
Beatriz Luna
MAMaría Fernanda García Aguilera
María Fernanda García Aguilera
MSMarcos Di Stefano
Marcos Di Stefano
High-risk human papillomavirus (HR-HPV) infection is the major risk factor for cervical cancer, which remains a significant concern, particularly in low and middle-income countries due to the lack of effective treatment and preventive measures. Examining the prevalence and distribution of HR-HPV is key to designing or reformulating policies aimed at eliminating HPV-associated cancers. A retrospective analysis was conducted using HR-HPV genotyping data from 9,524 women aged ≥18 years of the north-central region of Ecuador, who underwent cervical sampling either in cervical cancer prevention campaigns or during gynecological outpatient clinics, between January 2015 and August 2022. Samples were tested for HR-HPV using the cobas® 4800 HPV Test. Infection rates and genotype distributions were assessed across years, age groups, and provinces. Multivariable logistic regression was conducted to identify independent factors associated with HR-HPV infections. Potential association profiles among genotypes were explored through Multiple correspondence analysis. The overall prevalence of HR-HPV was 26.87% [95% CI: 25.98, 27.77]. In particular, HPV 16 was found in 8.64% [95% CI: 8.08, 9.22] of the participants, HPV 18 in 2.85% [95% CI: 2.52, 3.20], and Other HR-HPV in 19.41% [95% CI: 18.62, 20.22]. Fluctuating prevalence trends during the study period were determined, with Other HR-HPV as the only category with a positive trend (aAPC: 3.44% [95% CI: 0.89, 6.05]; p < 0.01). The age-specific infection rate of HR-HPV showed a bimodal distribution, with the younger women (18–24 years old) harboring the highest rate. A second peak was identified in the postmenopausal group of 65–69 years old. Relative to Pichincha, Imbabura exhibited 50% higher odds ratio of HPV 16 infection (p < 0.001), while Santo Domingo de los Tsáchilas had 27% and 30% lower odds of Overall HR-HPV and Other HR-HPV infections, respectively (p < 0.01). This study represents the largest-scale analysis on the epidemiology of HR-HPV in Ecuador. Given the high prevalence and positive trend of Other HR-HPV, our findings underscore the need for multivalent HPV vaccines. National screening strategies may consider screening of women over the age of 65 years when clinically indicated based on the patient history or physician judgment. Not applicable.

27 November 2019 in Virus Genes
Verified
Journal Article
Closed access
PDF file
Byron Francisco MosqueraByron Francisco Mosquera
Byron Francisco Mosquera
PGPatricia Garrido
Patricia Garrido
FFFrancisco J. Flores
Francisco J. Flores

3 August 2026 in Oxford Medical Case Reports
Verified
Journal Article
Open access
JSJohana Salgado
Johana Salgado
Estefanía Mariño-BritoEstefanía Mariño-Brito
Estefanía Mariño-Brito
Byron Francisco MosqueraByron Francisco Mosquera
Byron Francisco Mosquera
AGAnalia Ruales Guerra
Analia Ruales Guerra
JAJennia Joanna Acebo Arcentales
Jennia Joanna Acebo Arcentales
Background: Purpureocillium lilacinum is a ubiquitous environmental fungus widely utilized as an agricultural biocontrol agent, but it is increasingly recognized as an opportunistic human pathogen. While invasive fungal infections caused by this microorganism have been documented globally, disseminated systemic presentations in pediatric oncology remain exceptionally rare and carry high mortality rates. Case Description: We report the case of an 11-year-old female patient with a high-grade osteosarcoma who developed high-risk febrile leukopenia during chemotherapy. Blood cultures from both a subcutaneous port and peripheral blood turned positive for both yeast-like and hyphal structures, which were further identified by DNA barcoding (ITS and EF1a regions) as P. lilacinum. The patient exhibited concurrent multiorgan dissemination, including hyperchromic scaling skin lesions in the perianal region and limbs, as well as diffuse bilateral pulmonary micronodules confirmed via video-thoracoscopy biopsy. Despite initial treatment with amphotericin B and fluconazole, clinical resolution was successfully achieved only after optimizing the antifungal regimen with oral voriconazole. The patient fully recovered and remains stable. Conclusions: To our knowledge, this represents the first clinical isolation and reported case of disseminated systemic P. lilacinum infection in a pediatric oncological patient in Ecuador. This case highlights the aggressive nature of this pathogen in immunosuppressed children, the challenge of its diagnosis due to the lack of specialized infrastructure for antifungal susceptibility testing, and the critical importance of a multidisciplinary approach and prompt, targeted first-line therapy with voriconazole to ensure survival.